Founded in 1967, the group manufactures and sells proprietary electrophoresis instruments and reagents used in diagnostic and monitoring of specific protein disorders. Customers include biologists in laboratories, clinics and hospitals.
Historically focused on the diagnostic of cancer of the bone marrow (multiple myeloma), the group has over the years successfully extended its product portfolio to the diagnostic of genetic heamoglobin disorders and the monitoring of diabetes.
Its international business accounts for nearly three quarters of its sales across more than 110 countries.
